(Q40570235)

English

Recurrent childhood lymphocytic leukemia. Clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission

scientific article published on December 1, 1978

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Recurrent childhood lymphocytic leukemia. Clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission (English)

reason for preferred rank

most precise value

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

Recurrent childhood lymphocytic leukemia: clinical and cytokinetic studies of cytosine arabinoside and methotrexate for maintenance of second hematologic remission (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A282003

20 February 2023

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

author name string

G. Rivera

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A282003

20 February 2023

S. B. Murphy

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A282003

20 February 2023

R. J. Aur

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A282003

20 February 2023

M. S. Verzosa

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A282003

20 February 2023

G. V. Dahl

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A282003

20 February 2023

A. M. Mauer

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A282003

20 February 2023

language of work or name

0 references

publication date

1 December 1978

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

full work available at URL

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

42

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

2521-2528

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Dose-related synergism of cytosine arabinoside and methotrexate against murine leukemia L1210.

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197812%2942%3A6%3C2521%3A%3AAID-CNCR2820420603%3E3.0.CO%3B2-4

21 January 2018

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1002%2F1097-0142%28197812%2942%3A6%3C2521%3A%3AAID-CNCR2820420603%3E3.0.CO%3B2-4

21 January 2018

Cessation of Therapy during Complete Remission of Childhood Acute Lymphocytic Leukemia

1

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

Effects of cytosine arabinoside on the cell viability and uptake of deoxypyrimidine nucleosides in L5178Y cells

5

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

Cancer Research

6

35

1555

author name string

Edelstein

publication date

1975

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

Perturbation of cell cycle of human leukaemic myeloblasts in vivo by cytosine arabinoside

7

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

[Kinetics of human leukemic myeloblasts after use of cytosine-arabinoside]

8

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

Cancer Research

9

34

1883

author name string

Fridland

publication date

1974

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

Sequential use of methotrexate, folinic acid, and cytosine arabinoside in the treatment of acute leukemia

12

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

Chemotherapy of acute lymphoblastic leukemia in children

13

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

Cancer Research

14

33

521

author name string

Hoovis

publication date

1973

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

Treatment of leukemia with large doses of methotrexate and folinic acid: clinical-biochemical correlates

15

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

Synchronization and recruitment in acute leukemia

16

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

Toxicity of E. coli L-asparaginase in man

20

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

Recurrent childhood lymphocytic leukemia following cessation of therapy: treatment and response

23

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

“Total therapy” studies of acute lymphocytic leukemia in children. Current results and prospects for cure

28

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

Initial features and prognosis in 363 children with acute lymphocytic leukemia

29

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

Correlation of cytosine arabinoside-induced increment in growth fraction of leukemic blast cells with clinical response

30

1 reference

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

https://api.crossref.org/works/10.1002/1097-0142(197812)42:6%3C2521::AID-CNCR2820420603%3E3.0.CO;2-4

20 February 2023

Identifiers

10.1002/1097-0142(197812)42:6<2521::AID-CNCR2820420603>3.0.CO;2-4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40570235&oldid=1838010031"